Skip to main content
PMC home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1997 Dec;77(6):508–511. doi: 10.1136/adc.77.6.508

Respiratory syncytial virus genotypes and disease severity among children in hospital

J Fletcher 1, R Smyth 1, H Thomas 1, D Ashby 1, C Hart 1
PMCID: PMC1717415  PMID: 9496185

Abstract





OBJECTIVES—To determine the spectrum of N and G genotypes of respiratory syncytial virus (RSV) causing respiratory tract infection and whether particular genotypes are associated with severity of infection.
PATIENTS AND METHODS—Nasopharyngeal aspirates (NPAs) were obtained from 114 infants with acute respiratory tract infection due to RSV over two seasons. Viral mRNA was extracted from NPAs or cultured virus, reverse transcribed, and the cDNA amplified by the polymerase chain reaction using primers directed to parts of the N and G gene respectively. Amplicons were separately digested with four different restriction endonucleases for each gene. The fragments were separated by agarose gel, electrophoresis, and the electrophoretic patterns used to assign the various genotypes. Disease severity was assessed as very mild (upper respiratory tract signs only), mild (coryza and signs of lower respiratory tract infection), moderate (requiring nasogastric or intravenous fluids), and severe (requiring oxygen or ventilation).
RESULTS—Five of the six known N genotypes were detected, but NP4 and NP2 were found most frequently. There was no association between N genotype and disease severity. Six G (SHL) genotypes were detected. Significantly (p = 0.04) more of the infants infected with the SHL2 genotype had severe or moderate disease.
CONCLUSIONS—During the seasonal peaks of RSV respiratory tract infection at least 10 different RSV genotypes cocirculated. While there is no association between N genotypes and disease severity, infection with the SHL2 G genotype appears to result in moderate to severe disease.



Full Text

The Full Text of this article is available as a PDF (71.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alwan W. H., Record F. M., Openshaw P. J. CD4+ T cells clear virus but augment disease in mice infected with respiratory syncytial virus. Comparison with the effects of CD8+ T cells. Clin Exp Immunol. 1992 Jun;88(3):527–536. doi: 10.1111/j.1365-2249.1992.tb06482.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Anderson L. J., Heilman C. A. Protective and disease-enhancing immune responses to respiratory syncytial virus. J Infect Dis. 1995 Jan;171(1):1–7. doi: 10.1093/infdis/171.1.1. [DOI] [PubMed] [Google Scholar]
  3. Anderson L. J., Hierholzer J. C., Tsou C., Hendry R. M., Fernie B. F., Stone Y., McIntosh K. Antigenic characterization of respiratory syncytial virus strains with monoclonal antibodies. J Infect Dis. 1985 Apr;151(4):626–633. doi: 10.1093/infdis/151.4.626. [DOI] [PubMed] [Google Scholar]
  4. Berman S. Epidemiology of acute respiratory infections in children of developing countries. Rev Infect Dis. 1991 May-Jun;13 (Suppl 6):S454–S462. doi: 10.1093/clinids/13.supplement_6.s454. [DOI] [PubMed] [Google Scholar]
  5. Cane P. A., Matthews D. A., Pringle C. R. Analysis of respiratory syncytial virus strain variation in successive epidemics in one city. J Clin Microbiol. 1994 Jan;32(1):1–4. doi: 10.1128/jcm.32.1.1-4.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cane P. A., Matthews D. A., Pringle C. R. Identification of variable domains of the attachment (G) protein of subgroup A respiratory syncytial viruses. J Gen Virol. 1991 Sep;72(Pt 9):2091–2096. doi: 10.1099/0022-1317-72-9-2091. [DOI] [PubMed] [Google Scholar]
  7. Cane P. A., Pringle C. R. Molecular epidemiology of respiratory syncytial virus: rapid identification of subgroup A lineages. J Virol Methods. 1992 Dec 1;40(3):297–306. doi: 10.1016/0166-0934(92)90088-u. [DOI] [PubMed] [Google Scholar]
  8. Cane P. A., Pringle C. R. Respiratory syncytial virus heterogeneity during an epidemic: analysis by limited nucleotide sequencing (SH gene) and restriction mapping (N gene). J Gen Virol. 1991 Feb;72(Pt 2):349–357. doi: 10.1099/0022-1317-72-2-349. [DOI] [PubMed] [Google Scholar]
  9. Cane P. A., Thomas H. M., Simpson A. F., Evans J. E., Hart C. A., Pringle C. R. Analysis of the human serological immune response to a variable region of the attachment (G) protein of respiratory syncytial virus during primary infection. J Med Virol. 1996 Mar;48(3):253–261. doi: 10.1002/(SICI)1096-9071(199603)48:3<253::AID-JMV7>3.0.CO;2-7. [DOI] [PubMed] [Google Scholar]
  10. Collins P. L., Huang Y. T., Wertz G. W. Identification of a tenth mRNA of respiratory syncytial virus and assignment of polypeptides to the 10 viral genes. J Virol. 1984 Feb;49(2):572–578. doi: 10.1128/jvi.49.2.572-578.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Groothuis J. R., Gutierrez K. M., Lauer B. A. Respiratory syncytial virus infection in children with bronchopulmonary dysplasia. Pediatrics. 1988 Aug;82(2):199–203. [PubMed] [Google Scholar]
  12. Groothuis J. R., Simoes E. A., Levin M. J., Hall C. B., Long C. E., Rodriguez W. J., Arrobio J., Meissner H. C., Fulton D. R., Welliver R. C. Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group. N Engl J Med. 1993 Nov 18;329(21):1524–1530. doi: 10.1056/NEJM199311183292102. [DOI] [PubMed] [Google Scholar]
  13. Hall C. B., Walsh E. E., Schnabel K. C., Long C. E., McConnochie K. M., Hildreth S. W., Anderson L. J. Occurrence of groups A and B of respiratory syncytial virus over 15 years: associated epidemiologic and clinical characteristics in hospitalized and ambulatory children. J Infect Dis. 1990 Dec;162(6):1283–1290. doi: 10.1093/infdis/162.6.1283. [DOI] [PubMed] [Google Scholar]
  14. Kim H. W., Arrobio J. O., Brandt C. D., Jeffries B. C., Pyles G., Reid J. L., Chanock R. M., Parrott R. H. Epidemiology of respiratory syncytial virus infection in Washington, D.C. I. Importance of the virus in different respiratory tract disease syndromes and temporal distribution of infection. Am J Epidemiol. 1973 Sep;98(3):216–225. doi: 10.1093/oxfordjournals.aje.a121550. [DOI] [PubMed] [Google Scholar]
  15. Kim H. W., Canchola J. G., Brandt C. D., Pyles G., Chanock R. M., Jensen K., Parrott R. H. Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. Am J Epidemiol. 1969 Apr;89(4):422–434. doi: 10.1093/oxfordjournals.aje.a120955. [DOI] [PubMed] [Google Scholar]
  16. Kneyber M. C., Brandenburg A. H., Rothbarth P. H., de Groot R., Ott A., van Steensel-Moll H. A. Relationship between clinical severity of respiratory syncytial virus infection and subtype. Arch Dis Child. 1996 Aug;75(2):137–140. doi: 10.1136/adc.75.2.137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Laing I., Reidel F., Yap P. L., Simpson H. Atopy predisposing to acute bronchiolitis during an epidemic of respiratory syncytial virus. Br Med J (Clin Res Ed) 1982 Apr 10;284(6322):1070–1072. doi: 10.1136/bmj.284.6322.1070. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. McConnochie K. M., Hall C. B., Walsh E. E., Roghmann K. J. Variation in severity of respiratory syncytial virus infections with subtype. J Pediatr. 1990 Jul;117(1 Pt 1):52–62. doi: 10.1016/s0022-3476(05)82443-6. [DOI] [PubMed] [Google Scholar]
  19. McConnochie K. M., Roghmann K. J. Wheezing at 8 and 13 years: changing importance of bronchiolitis and passive smoking. Pediatr Pulmonol. 1989;6(3):138–146. doi: 10.1002/ppul.1950060303. [DOI] [PubMed] [Google Scholar]
  20. McIntosh E. D., De Silva L. M., Oates R. K. Clinical severity of respiratory syncytial virus group A and B infection in Sydney, Australia. Pediatr Infect Dis J. 1993 Oct;12(10):815–819. doi: 10.1097/00006454-199310000-00004. [DOI] [PubMed] [Google Scholar]
  21. Mlinaric-Galinovic G., Chonmaitree T., Cane P. A., Pringle C. R., Ogra P. L. Antigenic diversity of respiratory syncytial virus subgroup B strains circulating during a community outbreak of infection. J Med Virol. 1994 Apr;42(4):380–384. doi: 10.1002/jmv.1890420410. [DOI] [PubMed] [Google Scholar]
  22. Parrott R. H., Kim H. W., Arrobio J. O., Hodes D. S., Murphy B. R., Brandt C. D., Camargo E., Chanock R. M. Epidemiology of respiratory syncytial virus infection in Washington, D.C. II. Infection and disease with respect to age, immunologic status, race and sex. Am J Epidemiol. 1973 Oct;98(4):289–300. doi: 10.1093/oxfordjournals.aje.a121558. [DOI] [PubMed] [Google Scholar]
  23. Smyth R. L., Fletcher J. N., Thomas H. M., Hart C. A. Immunological responses to respiratory syncytial virus infection in infancy. Arch Dis Child. 1997 Mar;76(3):210–214. doi: 10.1136/adc.76.3.210. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Stott E. J., Taylor G. Respiratory syncytial virus. Brief review. Arch Virol. 1985;84(1-2):1–52. doi: 10.1007/BF01310552. [DOI] [PubMed] [Google Scholar]
  25. Straliotto S. M., Roitman B., Lima J. B., Fischer G. B., Siqueira M. M. Respiratory syncytial virus (RSV) bronchiolitis: comparative study of RSV groups A and B infected children. Rev Soc Bras Med Trop. 1994 Jan-Mar;27(1):1–4. doi: 10.1590/s0037-86821994000100001. [DOI] [PubMed] [Google Scholar]
  26. Sullender W. M., Mufson M. A., Anderson L. J., Wertz G. W. Genetic diversity of the attachment protein of subgroup B respiratory syncytial viruses. J Virol. 1991 Oct;65(10):5425–5434. doi: 10.1128/jvi.65.10.5425-5434.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Taylor C. E., Morrow S., Scott M., Young B., Toms G. L. Comparative virulence of respiratory syncytial virus subgroups A and B. Lancet. 1989 Apr 8;1(8641):777–778. doi: 10.1016/s0140-6736(89)92592-0. [DOI] [PubMed] [Google Scholar]
  28. Walsh E. E., McConnochie K. M., Long C. E., Hall C. B. Severity of respiratory syncytial virus infection is related to virus strain. J Infect Dis. 1997 Apr;175(4):814–820. doi: 10.1086/513976. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES